DUKE UNIVERSITY HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $72.1M
- Transactions
- 3,809
- Companies
- 40
- Average per transaction
- $18,941
Who reported the payments
| CSL Behring | $26,070,741 |
| Purdue Pharma L.p. | $4,650,511 |
| Siemens Medical Solutions USA, Inc. | $3,188,384 |
| Transmedics, Inc. | $2,797,767 |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,632,500 |
| Merck | $2,412,827 |
| Radius Health, Inc. | $2,297,721 |
| Heartflow, Inc. | $1,896,410 |
| Leadiant Biosciences, Inc. | $1,590,261 |
| Edwards Lifesciences | $1,582,679 |
| Exactech, Inc. | $1,059,781 |
| Philips North America LLC | $977,446 |
| GE HealthCare | $966,240 |
| E.r. Squibb & Sons, L.L.C. | $926,052 |
| AstraZeneca | $873,849 |
| Veloxis Pharmaceuticals, Inc. | $862,917 |
| Paragon 28, Inc. | $775,117 |
| Amicus Therapeutics, Inc. | $754,554 |
| Servier Pharmaceuticals LLC | $730,981 |
| SPR Therapeutics, Inc | $612,327 |
| Sumitomo Pharma America, Inc. | $588,243 |
| Angiodynamics, Inc. | $567,000 |
| Zynex Monitoring Solutions | $476,855 |
| Astrazeneca UK Limited | $452,967 |
| Agios Pharmaceuticals, Inc. | $414,187 |
| Diagnostica Stago, Inc | $367,886 |
| Abbott | $366,163 |
| Fresenius Kabi USA, LLC | $363,237 |
| Adlon Therapeutics L.p. | $363,225 |
| Masimo Corporation | $356,706 |
| Bluewind Medical | $333,973 |
| Xvivo Perfusion Inc. | $324,990 |
| C. R. Bard, Inc. & Subsidiaries | $320,437 |
| Acist Medical Systems, Inc. | $300,422 |
| Miach Orthopaedics, Inc. | $296,612 |
| W. L. Gore & Associates, Inc. | $293,353 |
| Janssen Research & Development, LLC | $287,885 |
| Amgen | $268,632 |
| Acumed LLC | $262,287 |
| Biofire Diagnostics, LLC | $244,155 |